Search for: "AMGEN INC."
Results 441 - 460
of 704
Sorted by Relevance
|
Sort by Date
12 Mar 2016, 12:48 pm
Although Tecfidera's pill form does improve patient compliance, Roche has a injectable multiple sclerosis candidate, ocrelizumab, that could slow Tecfidera's growth even further, as it might only require administration once every six months. link: http://www.fool.com/investing/general/2016/03/10/better-buy-amgen-inc-vs-biogen.aspxAs to administration, Tecfidera (whose chemical identity is simply methyl esters of fumaric acid) is oral, while ocrelizumab is a monoclonal… [read post]
8 Mar 2023, 2:51 pm
” Amgen Inc. v. [read post]
6 Oct 2008, 7:23 am
For this proposition, Impax cites this court's opinion in Amgen Inc. v. [read post]
1 May 2023, 10:11 am
Teva Pharmaceuticals USA, Inc. v. [read post]
20 Apr 2018, 8:41 am
Amgen, Inc., 475 F.3d 1256,1265 (Fed. [read post]
29 Dec 2022, 12:10 pm
While some courts have found a plaintiff’s motion for class certification to be deficient where the plaintiff’s expert did not conduct a consumer survey, Amgen Inc. v. [read post]
31 Dec 2013, 1:18 am
Techhealth, Inc. [read post]
19 Mar 2018, 7:02 pm
” Amgen Inc. v. [read post]
28 Aug 2007, 1:00 pm
Amgen, Inc.. [read post]
4 Mar 2016, 12:25 pm
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
5 Mar 2021, 8:15 am
The petition in Goldman Sachs Group, Inc. v. [read post]
11 Apr 2016, 2:38 am
Advocate General delivers opinion in United Video Properties, Inc v Telenet NV, C-57/15. [read post]
23 Jan 2024, 3:43 am
Vanda Pharmaceuticals Inc., v. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
15 Mar 2012, 5:00 am
Amgen Inc., 272 Fed. [read post]
12 Dec 2014, 10:21 am
Catalyst Pharmaceutical Partners, Inc., 2014 WL 4814352 (S.D. [read post]
4 Feb 2010, 11:50 am
Amgen, Inc., the California Court of Appeal reversed the trial court's determination that an employment agreement containing an arbitration agreement was unenforceable because it limited the parties each to one percipient or eye witness deposition, unless the arbitrator decides additional depositions are necessary based on a showing of need. [read post]
19 Mar 2008, 3:17 pm
The ITC's jurisdiction under § 1337, according to the court, is broad, and it therefore erred in holding that it lacked jurisdiction absent an actual sale or contract for sale of the imported product.More detail of Amgen, Inc. v. [read post]
27 Jul 2020, 2:04 am
., AbCellera Biologics, Amgen Inc., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
3 Oct 2012, 5:15 pm
Amnesty International USA, regarding the right to challenge the constitutionality of a global terrorism wiretapping program; Amgen Inc. v. [read post]
